Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05809323 · ClinicalTrials.gov registry record · NA
Marfan Syndrome Moderate Exercise Trial II
A NA study of Marfan Syndrome, sponsored by Baylor College of Medicine.
- Recruiting
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT05809323: Recruiting NA study of Marfan Syndrome, sponsored by Baylor College of Medicine.
NCT05809323 is a NA study of Marfan Syndrome that is actively recruiting participants, run by Baylor College of Medicine. The registered enrollment target is 50 participants, below the 390-participant average among 4 other Marfan Syndrome trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05809323, a NA study of Marfan Syndrome, is actively recruiting participants, sponsored by Baylor College of Medicine.
- RECRUITING
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
Marfan syndrome (MFS) is a distinctive connective tissue disorder that affects multiple organ systems including the heart, bones, ligaments, and eyes, and is associated with significant risk of aortic dissection. Given limited evidence from in-vitro studies, and theoretical concerns, the majority of patients with MFS are restricted from certain physical activities. The lack of exercise and deconditioning have detrimental effects including increasing weakness, joint pain, decreased endurance, and depressive symptoms. Given the significant paucity of data currently existing on the effects of exercise in humans with MFS, and the recent, optimistic findings in rodent models, this pilot trial was established to assess the effects of moderated dynamic exercise in adolescents and young adults with MFS.
Primary Outcome
Maximum VO2 in ml/kg/minute will be collected via Exercise Stress Test. Range 30-85, higher is better.
Conditions Studied
Interventions
- OTHER Control Group
- OTHER Exercise Intervention Group
Study Locations (1)
Texas
- Texas Children's Hospital - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2023-09-01 |
| Est. Completion | 2027-07-01 |
| Phase | NA |
What NCT05809323 shows while recruiting
NCT05809323 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 390-participant average among 4 other Marfan Syndrome trials with a reported enrollment target (87% lower).
The record links to 1 condition, with Marfan Syndrome appearing as the primary indexed condition, and to 2 interventions - of which Control Group is the first listed.
NCT05809323 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT05809323 about?
NCT05809323 is a clinical study titled "Marfan Syndrome Moderate Exercise Trial II". Marfan syndrome (MFS) is a distinctive connective tissue disorder that affects multiple organ systems including the heart, bones, ligaments, and eyes, and is associated with significant risk of aortic dissection. Given limited evidence from in-vitro studies, and theoretical concerns, the majority of...
What is the current status of trial NCT05809323?
This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2023-09-01. Estimated completion is 2027-07-01.
What conditions does trial NCT05809323 study?
This clinical trial studies the following conditions: Marfan Syndrome.
What interventions are being tested in trial NCT05809323?
The interventions under investigation include: Control Group (OTHER), Exercise Intervention Group (OTHER).
Who is sponsoring clinical trial NCT05809323?
This trial is sponsored by Baylor College of Medicine, which has 616 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05809323 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Marfan Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Complex Aortic Aneurysm Repair Using Physician Modified Endografts and Custom Made Devices
RECRUITING · NA
-
Study of Heritable Connective Tissue Disorders
COMPLETED
-
Effects of Losartan Versus Atenolol on Aortic and Cardiac Muscle Stiffness in Adults With Marfan Syndrome
COMPLETED · Phase 3
-
Micro RNAs as a Marker of Aortic Aneurysm in Hereditary Aortopathy Syndromes
COMPLETED
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI